JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (5): 453-458.doi: 10.3969/j.issn.1005-6483.2022.05.015

Previous Articles     Next Articles

Expression of forkhead box Q1 and CyclinD1 in non-small cell lung cancer and their relationship with clinicopathological features and prognosis

  

  1. Department of Cardiothoracic Surgery,the First People’s Hospital of Yibin City,Sichuan,Yibin 644000,China
  • Received:2021-06-10 Accepted:2021-06-10 Online:2022-05-20 Published:2022-06-20

Abstract: [Abstract] Objective To explore the expression levels of FOXQ1 and CyclinD1 in non-small cell lung cancer (NSCLC),and analyze their relationship with clinicopathological features and prognosis. Methods 196 cancer tissue samples and 30 adjacent tissue samples of NSCLC patients treated in our hospital from December 2014 to October 2017 were selected.The expressions of FOXQ1 and cyclinD1 protein in NSCLC tissues and adjacent tissues were detected by EnVisio immunohistochemistry.The expression levels of FOXQ1 and CyclinD1 in NSCLC and their relationship with clinicopathological parameters were analyzed.Spearman correlation was used to analyze the correlation between FOXQ1 and CyclinD1.Cox proportional hazards regression model was used to analyze the prognostic factors of NSCLC patients.Kaplan Meier survival curve was used to analyze the relationship between the expression of FOXQ1 and CyclinD and the prognosis. Results The high expression rates of FOXQ1 and cyclinD1 protein in NSCLC tissues were higher than those in paracancerous tissues (P<0.05).The high expression of FOXQ1 and CyclinDl in NSCLC was correlated with pathological differentiation,clinical stage and lymph node metastasis (P<0.05).Spearman correlation analysis showed that there was a positive correlation between foxq1 expression and CyclinD1 expression in NSCLC (P<0.05).Cox regression analysis showed that high expression of FOXQ1,CyclinD1 and FOXQ1+CyclinD1 were independent risk factors for progression free survival (PFS) and overall survival (OS) of NSCLC patients (P<0.05).Kaplan Meier analysis showed that the cumulative survival rates of PFS and OS in patients with high expression of FOXQ1 and CyclinDl were lower than those in other patients (P<0.05).The cumulative survival rates of PFS and OS in patients with high expression of FOXQ1 and CyclinDl were lower than those in patients with high expression of FOXQ1 and CyclinD1 alone (P<0.05).Conclusion FOXQ1 and CyclinD1 are highly expressed in NSCLC tissues,which are closely related to the occurrence,development and prognosis of the disease.FOXQ1 and cyclinD1 protein are positively correlated,the combined detection of both can better judge the prognosis of NSCLC patients.

Key words: non-small cell lung cancer, forkhead box Q1, CyclinD1, prognosis, clinical pathology features

[1] LI Zongfu, CHEN Tieliang, DING Mei, et al. Analysis of the effect of rapid rehabilitation surgery on the nutritional status of patients undergoing laparoscopic-assisted pyloric sparing gastrectomy for early gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 433-436.
[2] RUAN Tian, LI Changsheng, YANG Zetian, et al. The effect of visceral pleural invasion on the survival of postoperative patients with stage ⅢA/N2 non-small cell lung cancer:SEER database analysis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 448-452.
[3] BIAN Chunan, TIAN Xiaoqi, LIN Chaoyu, et al. Differentiated expression and clinical significance of crystallin-alpha B in lung squamous cell carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 486-489.
[4] YANG Heng, ZHANG Jun, GUO Qiang, et al. The potential value of HLA-DPB1 in lung adenocarcinoma was analyzed based on multi-database [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 339-344.
[5] JIN Yi , WANG Xinyi, DU Runsen, et al. Decreased expression of hsa-mir-337 predicts poor prognosis in patients with breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 345-348.
[6] WANG Pengyuan, SHANG Yichao, ZHENG Duo, et al. Prognostic analysis of pelvis and ureteral carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 368-371.
[7] LU Kaijin, SHEN Jiangfeng, JIA Weiguang. Effect of thoracoscopic modified recurrent laryngeal nerve lymph node dissection for esophageal cancer and its effect on patient prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 257-260.
[8] SHEN Jian, LI Minzhe, DU Yanfu. Effect of central obesity on clinical efficacy of laparoscopic D2 radical gastrectomy for distal gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 261-265.
[9] LI Yuzhu, XIA Lianjie. Expression of Dickkopfrelated protein 2 in cancer tissues of patients with bladder cancer and its correlation with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 280-283.
[10] JI Jintao, KANG Bo, SU Yansheng. Relationship between prostate specific membrane antigen expression and clinicopathological features in prostate cancer patients and its prognostic value [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 130-133.
[11] LI Yunlong, DU Zhenghua, ZHANG Huimin, et al. Clinical treatment and prognostic analysis of gastrointestinal pancreatic neuroendocrine neoplasm [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 166-170.
[12] ZHANG Mingkun, WANG Zhe, YANG Liu, et al.. Analysis of prognostic factors and construction of prognostic models for mucinous breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(1): 44-50.
[13] SUN Zheng, QUE Haifeng, LOU Jian, et al.. Prognostic significance of nutritional risk index in stage Ⅳ gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(1): 58-61.
[14] HU Xinyu, YAO Hui, XIA Dong, et al.. Expression of C3G in gastric cancer tissure and the relation to the clinical features [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 848-852.
[15] JIANG Xiaoqin, LI Huizhen.. Safety and effectiveness study of simultaneous TURBT and TURP in treatment of non-muscle-invasive bladder cancer patients complicated by benign prostatic hyperplasia [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 872-875.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 772 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 783 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 816 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 819 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 821 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 824 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 831 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 835 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 839 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 844 .